Future Perspectives on Endoscopic Ultrasonography-Guided Therapy for Pancreatic Neoplasm.
- Author:
Woo Hyun PAIK
1
;
Sang Hyub LEE
;
Sunguk JANG
Author Information
- Publication Type:Review
- Keywords: EUS; Pancreatic neoplasms; Treatment outcome; Contraindications; Ethanol
- MeSH: Catheter Ablation; Consensus; Endosonography; Ethanol; Humans; Pancreatic Neoplasms*; Treatment Outcome
- From:Clinical Endoscopy 2018;51(3):229-234
- CountryRepublic of Korea
- Language:English
- Abstract: Endoscopic ultrasonography (EUS)-guided therapy with ethanol injection or catheter-based radiofrequency ablation for pancreatic neoplasm has been conducted as a potential alternate treatment modality for patients who are not eligible for surgery. On the basis of the limited number of studies available, EUS-guided ablation therapy with the aforementioned methods for small pancreatic neoplasms has demonstrated promising technical feasibility and safety profiles. To be considered as a legitimate alternative option to surgery, however, EUS-guided ablation therapy must provide a long-term efficacy profile along with the consensus among experts regarding its treatment parameter. This review focuses on the clinical issues and future perspectives of EUS-guided therapy for pancreatic neoplasm.
